NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Diana Shipping Ends Nine-Month Pursuit of Genco Amid Valuation Standoff

Diana Shipping walks away from Genco deal as board demands a 57% premium and nearly half the combined company.

Diana Shipping Ends Nine-Month Pursuit of Genco Amid Valuation Standoff
Credit: Genco Shipping & Trading
Already have an account? Sign in.
08/14/2026 · 5:06 PM
DSX
/ Don’t stop at just one post.

Related↓

Diana Shipping Raises Takeover Bid for Genco in Star Bulk Partnership
03/06/2026 · 2:58 PM

Diana Shipping Raises Takeover Bid for Genco in Star Bulk Partnership

Diana Shipping ups its cash offer for Genco Shipping to $23.50/share, backed by $1.43B bank financing and Star Bulk buying 16 vessels.

/ Subscriber only
/ Read more

Feed↓

FDA Approves First SMA Drug That Targets Muscle Loss, Not Just Nerves
Featured/ 09/11/2026 · 5:55 PM

FDA Approves First SMA Drug That Targets Muscle Loss, Not Just Nerves

The FDA approved Scholar Rock’s Isembyld, the first SMA therapy aimed at muscle wasting in patients already on nerve-targeted treatment.

/ Subscriber only
AstraZeneca’s Etcamah Combination Falls Short of Statistical Significance in SERENA-4
Featured/ 09/11/2026 · 4:48 PM

AstraZeneca’s Etcamah Combination Falls Short of Statistical Significance in SERENA-4

The Phase III SERENA-4 trial did not meet its primary PFS endpoint in untreated advanced ER-positive, HER2-negative breast cancer, despite a numerical benefit.

/ Subscriber only
Citi Says AppLovin Is Positioned to Meet or Beat Q3 Guidance
09/11/2026 · 4:30 PM

Citi Says AppLovin Is Positioned to Meet or Beat Q3 Guidance

Citi added a 90-day upside view on AppLovin with a $600 target, calling Q3 concerns misguided.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe